Flow Cytometry Market Size, Share, Growth Analysis, By Technology (Cell-Based, Bead-Based), Product & Service (Instruments, Software), Application (Research, Immunology), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2031 | Region: Global | Published Date: August, 2024
Pages: 157 |Tables: 130 |Figures: 77

Flow Cytometry Market Insights

Global Flow Cytometry Market was valued at USD 3.97 Billion in 2022 and is poised to grow from USD 4.25 Billion in 2023 to USD 6.99 Billion by 2031, at a CAGR of 7.17% over the forecast period (2024-2031).

Industry expansion is being driven by the rise in cancer, immune system problems, and infectious diseases. High demand for flow cytometry instruments is also a result of growing R&D expenditures in biotechnology, life science, and biopharmaceutical research activities. The development of microfluidic flow cytometry for Point-of-Care (POC) testing is one example of the new and improved analytical instruments being introduced by the technological improvements in the technique.

The test makes use of flow cytometry to provide crucial details about a patient's reaction to COVID-19 antigens and to assist in making wise treatment decisions. It is projected that such innovations would foster industry growth soon. Another reason influencing the adoption of flow cytometry techniques is the increased prevalence of infectious diseases worldwide.

US Flow Cytometry Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 3971.4 million

Largest Segment

Instruments

Fastest Growth

Instruments

Growth Rate

7.17% CAGR

Global Flow Cytometry Market ($ Mn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Flow Cytometry Market Segmental Analysis

The Global Flow Cytometry Market is segmented based on Product, Technology, Application, End-use, and Region. Based on Product it is categorized into: Instruments (Cell Analyzers, Cell Sorters), Reagents & Consumables, Software, Accessories, and Services. Based on Technology it is categorized into: Cell-based, Bead-based. Based on Application it is categorized into: Research (Pharmaceutical (Drug Discovery, Stem Cell, and In Vitro Toxicity), Apoptosis, Cell Sorting, Cell Cycle Analysis, Immunology, Cell Viability), Industrial, Clinical (Cancer, Organ Transplantation, Immunodeficiency, and Hematology). Based on End-use it is categorized into: Commercial Organizations, Hospitals, Academic Institutes, and Clinical Testing Labs. Based on region it is categorized into: North America, Europe, Asia-Pacific, South America, and MEA.

Analysis by Product

The instruments segment held the largest share of the market in 2023 and is expected to continue so throughout the forecast period. This high share could be attributed to technological advancements and the introduction of novel cytometers by key players. The high cost of these instruments also contributes to the segment's high revenue generation. Because of their increased adoption in diagnostics and research, the reagents and consumables segment held a significant revenue share in the flow cytometry market.

The software segment is expected to witness the highest CAGR from 2024 to 2031. This software is for acquiring cells and data research in the diagnostic applications. A wide range of the applications is expected to drive the market in the coming years. Furthermore, innovation by the leading companies has been identified as an important factor expected to drive the growth of this segment.

Analysis by Application

The clinical segment recorded the highest revenue share of 45.44% in 2023. This can be attributed to increasing R&D activities focused on cancer and infectious diseases with ongoing efforts in COVID -19 and increasing R&D investment in biotechnology and pharmaceutical industry which contributes to market expansion. Furthermore, continuous improvement strategies adopted by the key market players and introduction of innovative solutions for the clinical role will play an important role in supporting this sector's growth.

The industrial sector is expected to be the fastest growing sector from 2024 to 2031 due to increasing applications in microbiology, tissue culture, food industry, plant tissue culture, etc. Food microbiology uses flow cytometry to monitor food security. It also has applications in cellular measurements in food microorganisms, bioanalysis & cell counts, detection of foodborne pathogens, antimicrobial susceptibility testing, biopreservation. Thus, food industry growth is expected in developed countries and countries in a newly developing field will provide useful opportunities for flow cytometry solutions.

Global Flow Cytometry Market By Technology (%)

To get detailed analysis on other segments, Request For Free Sample Report

Flow Cytometry Market Regional Insights

North America dominated the flow cytometry market. Throughout the forecast period, the region is predicted to dominate the marketplace. This dominance may be attributed to the United States' excessive healthcare spending and the healthcare infrastructure. Furthermore, the established pharmaceutical industry, as well as extensive research activities by research universities and pharmaceutical companies, have created a significant demand for the flow cytometry solutions for research purposes. North America dominated the overall market with 41.20% revenue share in 2023. This can be attributed in large part to the well-established healthcare and pharmaceutical industry in the US, which has driven the demand for flow cytometry solutions great for clinical and research purposes.

Asia-Pacific flow cytometry market is expected to witness the highest CAGR from 2024 to 2030 as driven by the growing medical biotechnology industry in emerging economies such as China and India. Furthermore, extensive research activities by regional players aimed at scaling up new flow cytometry solutions or will be created will drive the market growth in Asia Pacific throughout the estimated period.

During the forecast period, the market in the Asia Pacific is expected to grow at an exponential rate. Furthermore, continuous innovations in cancer and infectious disease research are estimated to contribute significantly to the regional market's growth. Major research activities by regional players aimed at developing new flow cytometry solutions are also anticipated to boost market expansion in Asia-Pacific during the forecast period.

Global Flow Cytometry Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Flow Cytometry Market Dynamics

Driver

Growing Demand for Generic Medicines

  • The increasing emphasis on the personalized medicine and targeted therapies is driving the demand for more advanced flow-through methods. The ability of flow cytometry to analyze multiple parameters simultaneously contributes to the accurate characterization of cells, which is crucial for developing personalized treatment plans.

Technological Advancements

  • New trends in flow cytometry technology, such as the development of more sensitive detectors and multiparameter analysis can increase the accuracy and efficiency of cytoanalysis. These developments expand the use of flow cytometry in research and clinical research, boosting the market

Restraint

Increased Equipment Costs

  • The initial investment and maintenance costs associated with flow cytometry equipment may be prohibitively high for some laboratories and institutions These financial barriers may prevent the uptake of flow cytometry especially in small or underfunded centers.

Complex Data Analysis

  • Flow cellular measurements yield complicated records that need sophisticated software programs and expertise for accurate interpretation. Complex statistical analysis and the need for specialized training can be a barrier to a hit adoption and hinder market growth.

Request Free Customization of this report to help us to meet your business objectives.

Flow Cytometry Market Competitive Landscape

The flow cytometry market is considered highly consolidated due to the presence of very few players in the market. These players hold a huge share of the market and are likely to remain in a similar competitive environment for the next few years. BD Biosciences is a leader in the flow cytometry market, known for its wide range of flow cytometry devices, reagents and software solutions. The company emphasizes innovation and product development to meet research and clinical needs.

Top Players Company Profiles

  • Becton, Dickinson, and Company (US)
  • Danaher Corporation (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Agilent Technologies, Inc. (US)
  • Sony Group Corporation (Japan)
  • Bio-Rad Laboratories, Inc. (US)
  • Miltenyi Biotec GmbH (Germany)
  • Enzo Biochem, Inc. (US)
  • Sysmex Corporation (Japan)
  • bioMérieux S.A. (France)
  • Cytonome/ ST, LLC (US)
  • Sartorius AG (Germany)
  • Cytek Biosciences, Inc. (US)
  • Union Biometrica, Inc. (US)
  • Fluxion Biosciences, Inc. (US)
  • Apogee Flow Systems Ltd. (UK)
  • Merck KGaA (Germany)
  • Beckman Coulter, Inc. (US)
  • Stratedigm, Inc. (US)
  • Nanocellect Biomedical (US)

Recent Developments

  • In June 2022, Becton, Dickinson, and Company announced the launch of new cell sorting technology at the International Society for Advancement of Cytometry (ISAC) CYTO 2022 conference. This new technology allows researchers to see and sort cells at speeds never before possible, potentially transforming research and cell-based therapeutic development across a variety of fields, including virology and oncology, as well as a variety of disease states.
  • In August 2021, Becton, Dickinson, and Company introduced the BD FACSymphony A1 Cell Analyzer, a new benchtop cell analyzer. The fluorescence-activated cell analyzer is expected to provide sophisticated flow cytometry capabilities to laboratories of all sizes.
  • In June 2021, The Invitrogen Attune CytPix Flow Cytometer from Thermo Fisher Scientific is an imaging-enhanced flow cytometer that combines acoustic focusing flow cytometry technology with a high-speed camera.

Flow Cytometry Key Market Trends

Revolutionizing Research and Diagnostics

  • Cell sorting is a pivotal segment of the flow cytometry market, appreciably enhancing the capability to split and analyze individual mobile populations based on specific characteristics. This procedure is essential for the various packages, consisting of cancer research, immunology, and stem mobile research. Advances in cell sorting technology permit researchers and clinicians to isolate rare cell types with high purity and accuracy, facilitating certain studies and personalized medicine procedures. The growing call for specific cellular analysis in both studies and clinical settings is driving the enlargement of this market section.

Flow Cytometry Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to SkyQuest analysis, the global flow cytometry market is expected to expand at a rapid pace in the coming years, owing to technological advancements and widespread adoption in a variety of research and diagnostic applications. Furthermore, the application of flow cytometry technology in new research fields such as cytogenomics, proteomics, and marine cell biology will help to expand the field. Moreover, increasing number of diseases, such as cancer and HIV is expected to promote the adoption of lymphocyte screening technology in diagnostic applications.

Report Metric Details
Market size value in 2022 USD 3.97 Billion
Market size value in 2031 USD 6.99 Billion
Growth Rate 7.17%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Products
    • Instruments (Cell Analyzers, Cell Sorters), Reagents & Consumables, Software, Accessories, Services
  • Technology
    • Cell-based, Bead-based
  • Application
    • Research (Pharmaceutical (Drug Discovery, Stem Cell, In Vitro Toxicity), Apoptosis, Cell Sorting, Cell Cycle Analysis, Immunology, Cell Viability), Industrial, Clinical (Cancer, Organ Transplantation, Immunodeficiency, and Hematology
  • End-Use
    • Commercial Organizations, Hospitals, Academic Institutes, Clinical Testing Labs
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Becton, Dickinson, and Company (US)
  • Danaher Corporation (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Agilent Technologies, Inc. (US)
  • Sony Group Corporation (Japan)
  • Bio-Rad Laboratories, Inc. (US)
  • Miltenyi Biotec GmbH (Germany)
  • Enzo Biochem, Inc. (US)
  • Sysmex Corporation (Japan)
  • bioMérieux S.A. (France)
  • Cytonome/ ST, LLC (US)
  • Sartorius AG (Germany)
  • Cytek Biosciences, Inc. (US)
  • Union Biometrica, Inc. (US)
  • Fluxion Biosciences, Inc. (US)
  • Apogee Flow Systems Ltd. (UK)
  • Merck KGaA (Germany)
  • Beckman Coulter, Inc. (US)
  • Stratedigm, Inc. (US)
  • Nanocellect Biomedical (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Flow Cytometry Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Flow Cytometry Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Flow Cytometry Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Flow Cytometry Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Flow Cytometry Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Flow Cytometry Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Flow Cytometry Market was valued at USD 3.97 Billion in 2022 and is poised to grow from USD 4.25 Billion in 2023 to USD 6.99 Billion by 2031, at a CAGR of 7.17% over the forecast period (2024-2031).

The flow cytometry market is considered highly consolidated due to the presence of very few players in the market. These players hold a huge share of the market and are likely to remain in a similar competitive environment for the next few years. BD Biosciences is a leader in the flow cytometry market, known for its wide range of flow cytometry devices, reagents and software solutions. The company emphasizes innovation and product development to meet research and clinical needs. 'Becton, Dickinson, and Company (US)', 'Danaher Corporation (US)', 'Thermo Fisher Scientific, Inc. (US)', 'Agilent Technologies, Inc. (US)', 'Sony Group Corporation (Japan)', 'Bio-Rad Laboratories, Inc. (US)', 'Miltenyi Biotec GmbH (Germany)', 'Enzo Biochem, Inc. (US)', 'Sysmex Corporation (Japan)', 'bioMérieux S.A. (France)', 'Cytonome/ ST, LLC (US)', 'Sartorius AG (Germany)', 'Cytek Biosciences, Inc. (US)', 'Union Biometrica, Inc. (US)', 'Fluxion Biosciences, Inc. (US)', 'Apogee Flow Systems Ltd. (UK)', 'Merck KGaA (Germany)', 'Beckman Coulter, Inc. (US)', 'Stratedigm, Inc. (US)', 'Nanocellect Biomedical (US)'

The increasing emphasis on the personalized medicine and targeted therapies is driving the demand for more advanced flow-through methods. The ability of flow cytometry to analyze multiple parameters simultaneously contributes to the accurate characterization of cells, which is crucial for developing personalized treatment plans.

Cell sorting is a pivotal segment of the flow cytometry market, appreciably enhancing the capability to split and analyze individual mobile populations based on specific characteristics. This procedure is essential for the various packages, consisting of cancer research, immunology, and stem mobile research. Advances in cell sorting technology permit researchers and clinicians to isolate rare cell types with high purity and accuracy, facilitating certain studies and personalized medicine procedures. The growing call for specific cellular analysis in both studies and clinical settings is driving the enlargement of this market section.

North America dominated the flow cytometry market. Throughout the forecast period, the region is predicted to dominate the marketplace. This dominance may be attributed to the United States' excessive healthcare spending and the healthcare infrastructure. Furthermore, the established pharmaceutical industry, as well as extensive research activities by research universities and pharmaceutical companies, have created a significant demand for the flow cytometry solutions for research purposes. North America dominated the overall market with 41.20% revenue share in 2023. This can be attributed in large part to the well-established healthcare and pharmaceutical industry in the US, which has driven the demand for flow cytometry solutions great for clinical and research purposes.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35H2031

$5,300
BUY NOW GET FREE SAMPLE